HRT Financial’s Edwards Lifesciences EW Stock Holding History

HRT Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.74M	Sell	34,242 -131,388	-79%	-$10.8M	0.01%	1391
2025 Q4	$14.1M	Buy	+165,630	New	+$13.6M	0.04%	323
2025 Q3	–	Sell	-81,657	Closed	-$6.39M	–	3068
2025 Q2	$6.39M	Buy	81,657 +76,908	+1,619%	+$5.74M	0.03%	446
2025 Q1	$344K	Buy	+4,749	New	+$340K	﹤0.01%	1701
2024 Q3	–	Sell	-68,653	Closed	-$6.34M	–	2630
2024 Q2	$6.34M	Buy	+68,653	New	+$6.08M	0.04%	335
2023 Q4	–	Sell	-12,742	Closed	-$882K	–	2520
2023 Q3	$882K	Sell	12,742 -54,186	-81%	-$4.35M	0.01%	1063
2023 Q2	$6.31M	Buy	+66,928	New	+$5.82M	0.06%	231
2022 Q4	–	Sell	-75,688	Closed	-$6.25M	–	2652
2022 Q3	$6.25M	Buy	+75,688	New	+$7.28M	0.07%	236
2021 Q4	–	Sell	-55,543	Closed	-$6.29M	–	3423
2021 Q3	$6.29M	Buy	+55,543	New	+$6.34M	0.04%	256
2021 Q1	–	Sell	-32,421	Closed	-$2.96M	–	2812
2020 Q4	$2.96M	Buy	+32,421	New	+$2.69M	0.06%	235
2020 Q2	–	Sell	-53,382	Closed	-$3.36M	–	1597
2020 Q1	$3.36M	Buy	+53,382	New	+$3.85M	0.22%	85
2019 Q3	–	Sell	-320,040	Closed	-$19.7M	–	1439
2019 Q2	$19.7M	Buy	+320,040	New	+$19.4M	1.24%	13

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HRT Financial's EW Position: Q1 2026 in Review

HRT Financial reduced its Edwards Lifesciences (EW) stake by 79% in Q1 2026, selling an estimated $10.8M and leaving 34,242 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #1391.

HRT Financial first reported a position in EW in Q2 2019 and has held it in 12 quarters since. The position peaked at $19.7M in Q2 2019. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

HRT Financial held 34,242 shares of Edwards Lifesciences worth $2.74M as of Q1 2026.
HRT Financial sold 131,388 Edwards Lifesciences shares in Q1 2026, an estimated $10.8M.
Edwards Lifesciences made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1391 holding.
HRT Financial first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 12 quarters since.
HRT Financial's Edwards Lifesciences position peaked at $19.7M in Q2 2019.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.